Article
Association of SLC22A1 rs622342 and ATM rs11212617 polymorphisms with metformin efficacy in patients with type 2 diabetes.
Pharmacogenetics and genomics - 1 Feb 2022
Chen Peixian, Cao Yumin, Guo Yali, Xu Qi, Wang Xiaozhu, Zhang Liuwei, Liu Zhike, Chen Dafang, Chen Shiyi, Chen Shenren
Abstract excerpt
Metformin is the first-choice oral anti-hyperglycemic drug for type 2 diabetes mellitus (T2DM) patients. There are controversies about the association of SLC22A1 rs622342, which was not reported in the Chinese population, and ataxia-telangiectasia mutated (ATM) rs11212617 polymorphisms with metformin efficacy in T2DM. Our study was to investigate the effects of the two single nucleotide polymorphisms on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
